HIV Prevention

  • Treatment as Prevention: An Introductory Factsheet

    "Treatment as prevention” is the use of combination antiretroviral therapy (ART) in HIV-positive individuals to preserve their health and reduce the risk of transmitting the virus. This fact sheet defines treatment as prevention, reviews the science behind it, and outlines priorities for advocating for its implementation.

  • Sister Studies: The Ring Study and ASPIRE

    The Ring Study and ASPIRE (A Study to Prevent Infection with a Ring for Extended Use) are described in this fact sheet. The two related trials showed that monthly use of a vaginal ring that delivers the antiretroviral drug dapivirine can help prevent HIV infection in women and is safe for long-term use.

  • Microbicides for HIV Prevention: an Introductory Factsheet

    This fact sheet explains what microbicides are and provides a brief overview of the state of microbicide research.

  • Microbicide Overview

    This document provides information on the potential of microbicides for HIV prevention, the next steps for the monthly dapivirine ring, and the research and development process.

  • IPM Clinical Trials

    This regularly updated resource includes a list of all the International Partnership for Microbicides’ ongoing and planned trials of dapivirine in the form of a ring, a tablet, and a ring combining dapivirine with maraviroc, another antiretroviral drug.

  • Why Microbicides for Women?

    The International Partnership for Microbicides explains why women urgently need a method they can use to protect themselves from HIV infection and describes the essential role microbicides could play in a comprehensive HIV prevention strategy.

  • Facilitating Regulatory Approval of Multipurpose Prevention Technologies for Sexual and Reproductive Health

    This two-page document outlines the response of the U.S. Agency for International Development to an unmet need for products that provide simultaneous protection against unintended pregnancy and sexually transmitted infections, including HIV, with specific focus on the Population Council's work toward facilitating regulatory approval for multipurpose prevention technologies.

  • Data Watch: Closing a Persistent Gap in the AIDS Response

    In Data Watch: Closing a Persistent Gap in the AIDS Response, AVAC and amFAR take stock of global progress toward ending the AIDS epidemic and lay out an agenda for improving accountability through better data collection. This document is an update to An Action Agenda to End AIDS, which includes clear, time-bound targets for outcomes, as well as the responsibilities of different stakeholders to achieve these targets.

  • - Private group -

    Situation Assessment of the HIV Response among Young People in Zambia

    The main objective of this situational assessment is to compile and synthesize existing recent information on HIV and young people together with the current AIDS response for young people in Zambia, including programmes, policies, and key partners, and to document gaps and challenges in the response. In this document young people refers to individuals aged 10 to 24 years.

  • HIV and Social Protection Guidance Note

    This guidance note summarises information on HIV-sensitive social protection, sets out key principles to provide a strong foundation for programming, and describes the potential of social protection to advance HIV prevention, treatment, care and support outcomes. This brief also presents case studies illustrating how HIV-sensitive social protection is working on the ground.